Showing results (291-300 of 308) with videos related to
Sort By:
Pageof 31
Nature|August 16, 2011
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammationMark C Siracusa, Steven A Saenz, David A Hill, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2019
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic AsthmaJonathan Corren, Mario Castro, Thomas O'Riordan, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitisWilliam W Busse, Jorge F Maspero, Yufang Lu, et al.Science Immunology|June 24, 2022
FOXP3 exon 2 controls Treg stability and autoimmunityJianguang Du, Qun Wang, Shuangshuang Yang, et al.Immunity|December 22, 2016
Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue FormationEtsushi Kuroda, Koji Ozasa, Burcu Temizoz, et al.The New England Journal of Medicine|May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaMario Castro, Jonathan Corren, Ian D Pavord, et al.The Journal of Allergy and Clinical Immunology. in Practice|July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic RhinosinusitisJorge F Maspero, Constance H Katelaris, William W Busse, et al.American Journal of Respiratory Cell and Molecular Biology|September 7, 2016
Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune ToleranceJohn A Gebe, Koshika Yadava, Shannon M Ruppert, et al.Chest|February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkersSebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.The Lancet. Respiratory Medicine|April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.Pageof 31